Li M - Search Results

1

7-Cycloalkylcamptothecin derivatives: Preparation and biological evaluation.

Li M, Jin W, Jiang C, Zheng C, Tang W, You T, Lou L. Li M, et al. Bioorg Med Chem Lett. 2009 Aug 1;19(15):4107-9. doi: 10.1016/j.bmcl.2009.06.010. Epub 2009 Jun 6. Bioorg Med Chem Lett. 2009. PMID: 19541483

2

Synthesis and antitumor activity of a series of lactone-opened camptothecin derivatives.

Zheng C, Li MZ, You TP, Tang WP, Lou LG. Zheng C, et al. J Asian Nat Prod Res. 2019 Jan;21(1):51-61. doi: 10.1080/10286020.2017.1392941. Epub 2017 Oct 24. J Asian Nat Prod Res. 2019. PMID: 29063792

3

Semi-synthesis and biological activity of gamma-lactones analogs of camptothecin.

Li M, Tang W, Zeng F, Lou L, You T. Li M, et al. Bioorg Med Chem Lett. 2008 Dec 15;18(24):6441-3. doi: 10.1016/j.bmcl.2008.10.074. Epub 2008 Oct 19. Bioorg Med Chem Lett. 2008. PMID: 18986807

4

Synthesis and Structure-Activity Relationship Study of 5a-Carbasugar Analogues of SL0101.

Li M, Li Y, Mrozowski RM, Sandusky ZM, Shan M, Song X, Wu B, Zhang Q, Lannigan DA, O'Doherty GA. Li M, et al. Among authors: li y. ACS Med Chem Lett. 2014 Nov 26;6(1):95-9. doi: 10.1021/ml5004525. eCollection 2015 Jan 8. ACS Med Chem Lett. 2014. PMID: 25589938 Free PMC article.

5

Identifying requirements for RSK2 specific inhibitors.

Wright EB, Fukuda S, Li M, Li Y, O'Doherty GA, Lannigan DA. Wright EB, et al. Among authors: li y, li m. J Enzyme Inhib Med Chem. 2021 Dec;36(1):1798-1809. doi: 10.1080/14756366.2021.1957862. J Enzyme Inhib Med Chem. 2021. PMID: 34348556 Free PMC article.

6

Pd(II)-catalyzed decarboxylative cross-coupling of potassium aryltrifluoroborates with α-oxocarboxylic acids at room temperature.

Li M, Wang C, Ge H. Li M, et al. Org Lett. 2011 Apr 15;13(8):2062-4. doi: 10.1021/ol200459v. Epub 2011 Mar 10. Org Lett. 2011. PMID: 21391715

7

Development of a RSK Inhibitor as a Novel Therapy for Triple-Negative Breast Cancer.

Ludwik KA, Campbell JP, Li M, Li Y, Sandusky ZM, Pasic L, Sowder ME, Brenin DR, Pietenpol JA, O'Doherty GA, Lannigan DA. Ludwik KA, et al. Among authors: li y, li m. Mol Cancer Ther. 2016 Nov;15(11):2598-2608. doi: 10.1158/1535-7163.MCT-16-0106. Epub 2016 Aug 15. Mol Cancer Ther. 2016. PMID: 27528706 Free PMC article.

8

Regioselective Synthesis of a C-4'' Carbamate,C-6'' n-Pr Substituted Cyclitol Analogue of SL0101.

Li Y, Sandusky ZM, Vemula R, Zhang Q, Wu B, Fukuda S, Li M, Lannigan DA, O'Doherty GA. Li Y, et al. Among authors: li m. Org Lett. 2020 Feb 21;22(4):1448-1452. doi: 10.1021/acs.orglett.0c00042. Epub 2020 Feb 3. Org Lett. 2020. PMID: 32009414 Free PMC article.

9

Stereoselective Synthesis and Evaluation of C6″-Substituted 5a-Carbasugar Analogues of SL0101 as Inhibitors of RSK1/2.

Li M, Li Y, Ludwik KA, Sandusky ZM, Lannigan DA, O'Doherty GA. Li M, et al. Among authors: li y. Org Lett. 2017 May 5;19(9):2410-2413. doi: 10.1021/acs.orglett.7b00945. Epub 2017 Apr 25. Org Lett. 2017. PMID: 28441024

10

Decarboxylative acylation of arenes with alpha-oxocarboxylic acids via palladium-catalyzed C-H activation.

Li M, Ge H. Li M, et al. Org Lett. 2010 Aug 6;12(15):3464-7. doi: 10.1021/ol1012857. Org Lett. 2010. PMID: 20670012

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

68,662 results

Search Page